{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:25:05Z","timestamp":1773231905162,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Androgenetic alopecia is a common progressive hair loss disorder that affects quality of life and often prompts long-term medical management. Oral minoxidil and oral dutasteride are widely used treatments, yet comparative data on their early clinical and microscopic effects remain limited. This study examined six-month changes in clinical severity and regional hair characteristics in men receiving different doses of oral minoxidil or oral dutasteride.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Men with clinically confirmed androgenetic alopecia received oral dutasteride 0.5 milligrams daily or oral minoxidil at doses of 1, 2.5, or 5 milligrams daily, with treatment selection guided by clinical judgment and patient preference. Standardized clinical staging and trichoscopic imaging of the fronto-parietal, temporal, and occipital scalp regions were performed at baseline, 3 months, and 6 months. Outcomes included changes in clinical severity and region-specific measures of hair density, hair shaft diameter, and follicular unit composition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-seven participants were enrolled, and forty-six completed the six-month assessment. Across the oral minoxidil groups, improvements in clinical severity scores were observed, whereas no statistically significant change was detected in the oral dutasteride group over the same period. Trichoscopic changes were generally modest across all treatment regimens, with no group demonstrating significant increases in total hair density. Selective, region- and dose-specific structural changes were noted, including a higher proportion of thicker hairs in the fronto-parietal region with oral dutasteride and increased hair shaft diameter in the occipital region with low-dose oral minoxidil. However, these findings were limited in scope and did not correspond to broad improvements across trichoscopic parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this exploratory, non-randomized clinical trial, oral minoxidil was associated with short-term improvements in clinical severity, while oral dutasteride did not demonstrate measurable early clinical change within the six-month follow-up. Trichoscopic findings were limited and did not consistently parallel clinical outcomes, suggesting that early therapeutic effects in routine practice may be more readily captured by clinical staging than by regional microscopic assessment. These observations should be interpreted cautiously given the study design and sample size, and they warrant confirmation in larger, randomized studies with longer follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1751116","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:58:44Z","timestamp":1771246724000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study"],"prefix":"10.3389","volume":"13","author":[{"given":"M.","family":"Larios-C\u00e1rdenas","sequence":"first","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.G.","family":"Qui\u00f1ones-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Le\u00f3n Quintero-Loreto","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Grover-P\u00e1ez","sequence":"additional","affiliation":[{"name":"Laboratory of Vascular Mechanics, Institute of Experimental and Clinical Therapeutics, University Center of Health Sciences, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Moreno-Alanis","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Qui\u00f1ones-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.R.","family":"Calder\u00f3n-Quiroz","sequence":"additional","affiliation":[{"name":"Hospital \u201cDr. Valent\u00edn G\u00f3mez Far\u00edas\u201d ISSSTE, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Carrillo-Manguart","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alcocer-Salas","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gonz\u00e1lez-Ru\u00edz","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Ramos-Zavala","sequence":"additional","affiliation":[{"name":"Laboratory of Vascular Mechanics, Institute of Experimental and Clinical Therapeutics, University Center of Health Sciences, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cardona-Muller","sequence":"additional","affiliation":[{"name":"Laboratory of Vascular Mechanics, Institute of Experimental and Clinical Therapeutics, University Center of Health Sciences, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.E.","family":"S\u00e1nchez-Due\u00f1as","sequence":"additional","affiliation":[{"name":"Dermatologic Institute of Jalisco \u201cDr. Jos\u00e9 Barba Rubio\u201d, University of Guadalajara","place":["Guadalajara, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"Devjani","year":"2023","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2021.2196","article-title":"Health-related quality of life, depression, and self-esteem in patients with androgenetic alopecia: a systematic review and meta-analysis","volume":"157","author":"Huang","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12016-025-09034-5","article-title":"Immune and non-immune interactions in the pathogenesis of androgenetic alopecia","volume":"68","author":"Xiao","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.3390\/ijms25052542","article-title":"The biology and genomics of human hair follicles: a focus on androgenetic alopecia","volume":"25","author":"Cuevas-Diaz Duran","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"17461","DOI":"10.3390\/ijms242417461","article-title":"mRNA levels of aromatase, 5\u03b1-reductase isozymes, and prostate cancer-related genes in plucked hair from young men with androgenic alopecia","volume":"24","author":"S\u00e1nchez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e13182","DOI":"10.1111\/dth.13182","article-title":"Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: a descriptive monocentric study","volume":"33","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","article-title":"Minoxidil: a comprehensive review","volume":"33","author":"Gupta","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3390\/jcm13071962","article-title":"Trichoscopy of androgenetic alopecia: a systematic review","volume":"13","author":"Kuczara","year":"2024","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"ljaf085","DOI":"10.1093\/bjd\/ljaf085.105","article-title":"P077 updates on trichoscopy in diagnosing scalp disorders: a systematic review of diagnostic accuracy, sensitivity and specificity","volume":"193","author":"Mehra","year":"2025","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jvc2.86","article-title":"Mapping the hair density, thickness, and volume in normal and androgenetic alopecia subjects with the digital microscope","volume":"2","author":"Chang","year":"2023","journal-title":"JEADV Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jaad.2025.09.031","article-title":"Oral minoxidil 2.5mg vs 5mg for male androgenetic alopecia: a double-blind randomized clinical trial","volume":"94","author":"Fonseca","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamadermatol.2024.0284","article-title":"Oral Minoxidil vs topical Minoxidil for male androgenetic alopecia: a randomized clinical trial","volume":"160","author":"Penha","year":"2024","journal-title":"JAMA Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1001\/jamadermatol.2021.5743","article-title":"Relative efficacy of minoxidil and the 5-\u03b1 reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis","volume":"158","author":"Gupta","year":"2022","journal-title":"JAMA Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1638496","DOI":"10.3389\/fmed.2025.1638496","article-title":"Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials","volume":"12","author":"Xia","year":"2025","journal-title":"Front Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00403-025-04264-1","article-title":"Evaluating the accuracy of patient-reported hair outcomes versus trichometric measurements in PRP therapy","volume":"317","author":"Brinks","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0974-7753.96080","article-title":"Value of trichoscopy versus trichogram for diagnosis of female androgenetic alopecia","volume":"4","author":"Galliker","year":"2012","journal-title":"Int J Trichol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/jocd.16177","article-title":"Divergent progression pathways in male androgenetic alopecia and female pattern hair loss: trichoscopic perspectives","volume":"23","author":"Kamishima","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"38280","DOI":"10.1038\/s41598-025-23561-3","article-title":"Enhanced stratification of male pattern hair loss using AI through novel loss region ratio analysis","volume":"15","author":"Xi","year":"2025","journal-title":"Sci Rep"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1751116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:44:35Z","timestamp":1773157475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1751116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":19,"alternative-id":["10.3389\/fmed.2026.1751116"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1751116","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"article-number":"1751116"}}